Hence, targeted liposomes increased PD1+ /CD8+ T cells in tumor microenvironment, indicating that the PD-L1 blockage might reinvigorate antitumor immune function, which would be facilitated by Dox cytotoxicity, increasing the antigen release. Here, PDCD1 is linked to neoplasm.